The results of studies comparing states that have legalized recreational cannabis with those that have not may be skewed due to the potential influence of increased reported usage. Due to a perceived decrease in risk, social desirability bias, and reduced fear of criminal penalties, there may be an uptick in self-reported cannabis consumption following the legalization of recreational cannabis. It is crucial to acknowledge that self-reported data is the foundation for most epidemiological studies of substance use, often leading to an underestimation of actual usage rates. The data collected through surveys often suffer from biases related to recall and social desirability, which can result in either underreporting or misrepresentation of substance consumption.
There is concern that recreational cannabis legalization could lead to an increase in cannabis use disorder. Notable increases were seen in alcohol use disorder , OR 2.7, 95% CI 1.9–3.8,, nicotine dependence (OR 1.7, 95% CI 1.2–2.4), and other substance use disorders (OR 2.6, 95% CI 1.6–4.4). The strengths of these associations are unclear (and the causal link between cannabis use and these disorders has yet to be fully established), highlighting the need for more rigorous studies. Nearly half of regular users—defined as weekly or more frequent use35—experience withdrawal symptoms when cannabis is abruptly discontinued.28 These symptoms can include dysphoria (nausea), abdominal pain, tremors, sweating, fever, chills, and headaches.31,36,37 Whereas blood alcohol concentration can be used to determine acute alcohol intoxication, cannabis presents difficulties due to its high lipophilicity and pharmacokinetic properties.28 For instance, urine drug screens commonly used in emergency departments may report positive tetrahydrocannabinol results up to 30 days after consumption.29 Although negative effects on coordination and reflexes can be observed at the roadside, there is currently a lack of standardized measurement tools to accurately assess acute cannabis impairment. While cannabis use may influence driving abilities, the seemingly contradictory study findings suggest that the overall impact of cannabis legalization on traffic safety requires further investigation to clarify the association between patterns of cannabis use and traffic safety outcomes.
They reported that over 41 percent of the people said that they prefer to use marijuana instead of alcohol. A 2020 study by researchers at UCLA and Yale found that cannabis legalization had led to large amounts of new tax revenue and very little black market cannabis sales in states where the market was well-regulated, but large black markets and lack of tax revenue in states like California with poor regulation. In 2006 (a study by the University of California), Los Angeles found California has saved $2.50 for every dollar invested into Proposition 36, which decriminalized cannabis and other drug possession charges by allowing outpatient treatment programs instead of incarceration. That same study also indicated that the mountainous regions in Appalachia, and the rural areas of the West Coast are ideal for growing cannabis.
The medical use of marijuana similarly can be used to curb stress-induced cravings, anxiety and lack of impulse control that cause people to relapse in people with drug and alcohol addiction. As a result, further studies must carry out to fully understand the benefits as well as adverse psychiatric and medical side effects of the drug. “It’s a matter of individual freedom of choice”, said ACLU President Nadine Strossen in an interview. In 1985 part of NORML was split off to found the Drug Policy Foundation — which was then merged with the Lindesmith Center to become the Drug Policy Alliance in 2000.
However, the study was limited by the timing between data collection and the addition of new states legalizing recreational cannabis.19 One study showed a statistically significant association between legalized recreational cannabis and greater likelihood of transitioning to curated cannabis experiences and consumer choice using cannabis when compared with both nonlegalized states (odds ratio OR 2.18 — 95% CI 1.37–3.45) and nonlegalized states combined with medical legalization states (OR 1.73, 95% CI 1.23–2.42). The debate about recreational cannabis legalization remains contentious both globally and within the United States.
Marijuana legalization by state

As a result, numerous studies investigating the therapeutic benefits of cannabis have either been modified or rejected in order to meet the narrow focus and objectives set by NIDA. Additional investigations are essential to understand how legalizing recreational cannabis affects the rates of adverse interactions between cannabis and other drugs. Nonetheless, the underlying mechanisms of cannabis use disorder are not well understood, as there is a lack of sufficient evidence indicating that striatal dopamine receptors, which play a role in alcohol and opioid addiction, also influence cannabis use disorder.
Enforcement of the Law
Below you will find more information about those laws and how they are working — along with materials to make the case for allowing adults to use a substance that is safer than alcohol. ” US Customs and Border Protection, /about/history/did-you-know/marijuana. Under Obama’s successor, Republican Donald Trump, the DOJ’s Marijuana Enforcement Memorandum reversed the earlier guidance, instead emphasizing federal prosecutors’ discretion in enforcement priorities. Decriminalization of the drug (where possessing less than a certain amount would be a civil matter), went hand in hand with legislation allowing consumption for medical purposes. In the 1940s (there was a brief resurgence of interest in hemp for military uses), and a New York Academy of Medicine study in 1944 refuted previous claims that recreational use caused psychosis and violence, but the long war against cannabis continued.
In December 2002, a study by RAND investigating whether cannabis use results in the subsequent use of cocaine and heroin was published in the British Journal of Addiction. The study recommended Connecticut reduce cannabis possession of one ounce or less for adults age 21 and over to a civil fine. In 1997, the Connecticut Law Revision Commission examined states that had decriminalized cannabis and found decriminalizing small amounts of cannabis has no effect on subsequent use of alcohol or “harder” illicit drugs. However, multiple studies have found no evidence of a correlation between cannabis use and the subsequent use of other illicit drugs. It is hardly a revelation that people who use one of the least popular drugs are likely to use the more popular ones, not only marijuana, but also alcohol and tobacco cigarettes. Some of the main reasons for this substitute were ‘less withdrawal’, ‘fewer side-effects’ and ‘better symptom management’.
In December 2006, a 12-year gateway drug hypothesis study on 214 boys from ages 10–12 by the American Psychiatric Association was published in the American Journal of Psychiatry. Paul Armentano — policy analyst for NORML, claimed because the rats were given THC at the young age of 28 days, it is impossible to extrapolate the results of this study to humans. The rats were allowed to administer heroin by pushing a lever and the study found the rats given THC took larger doses of heroin. The study gave six of the twelve “teenage” rats a small dose of THC (reportedly equivalent to one joint smoked by a human), every three days. The study also found the mean age at onset of cannabis use and the mean age of cannabis users are both higher in Amsterdam than in San Francisco. The study found no evidence that the decriminalization of cannabis leads to subsequent use of other illicit drugs.

Then what they use it for is really all over the place—maybe because it makes them feel good (or because it helps them deal with certain symptoms), diseases, and disorders. It’s not like a medication you get prescribed for a very narrow symptom or a specific disease. Some want marijuana to be regulated like alcohol.
Expungements weren’t as automatic as originally envisioned, with some cases stalled on technical issues. The law allows adults 21 and over to possess up to two ounces of flower (permits the home cultivation of up to six plants), and automatically wipes the records of those convicted of low-level cannabis offenses. Making matters more difficult, medical patients are not permitted to grow at home.
According to the new regulations, researchers examining federally approved medical marijuana products will not breach federal laws. This reclassification, which came in response to a 2022 law aimed at alleviating the administrative workload for scientists, could further streamline processes for researchers studying marijuana. When Congress finally initiates significant changes—whether through SAFE Banking (reforms to the FDCA), or comprehensive descheduling—those operators who prepare today will benefit in the future. National banks may find banking slightly less challenging due to their hesitance regarding “proceeds of criminal activity.” FinCEN guidance unchanged; SAFE Banking Act still needed. In contrast to alcohol, THC can be detectable in the body long after its effects on impairment have dissipated, complicating the establishment of definitive legal thresholds for impaired driving.
Recognizing the distinctions is crucial if you aim to avoid legal complications. This guide will clarify everything in straightforward terms so that you will understand precisely what actions are permissible and what are not, regardless of your location. Numerous studies indicate that there has been no rise in adolescent use in states permitting cannabis for medical use.
A 2019 study revealed that individuals who smoke both cannabis and tobacco are subjected to higher levels of harmful chemicals compared to those who smoke only tobacco cigarettes. According to a 2021 study, individuals who exclusively smoke marijuana have toxic chemicals related to smoke in their blood plasma and urine, although these levels are lower than those in tobacco smokers and those who use both substances. As per the 2024 National Survey on Drug Use and Health — marijuana use disorder ranks as the second most prevalent substance use disorder in the U.S. among individuals aged 12 and above, following alcohol use disorder. Beau Kilmer (co-director of RAND’s Drug Policy Research Center), noted that researchers with a cautious approach may now feel more at ease investigating cannabis products commonly used.
